"UB-312 is designed to modify the course of Parkinsons disease by targeting the underlying cause," explained Lou Reese, co-founder of Vaxxinity, the Texas-based pharmaceutical company that collaborated on the study
GLP1 Medications Show New Benefits New research presented at ENDO 2025, the Endocrine Societys leading international conference on hormone science, reveals that GLP1 medications like semaglutide, dulaglutide, and tirzepatide may raise testosterone levels in men with obesity and type 2 diabetes
As a result, IGF-1 LR3 exhibits a significantly extended functional half-life compared to native IGF-1 in research systems
Eligibility may include confirming affiliation with recognized or approved organizations, validating the accuracy of information submitted, and identifying potential inconsistencies, misrepresentations, or falsification of account details
"Online dating apps can be invaluable tools for connecting with others